These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 11504920)
1. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Cooper JD; Salehi A; Delcroix JD; Howe CL; Belichenko PV; Chua-Couzens J; Kilbridge JF; Carlson EJ; Epstein CJ; Mobley WC Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10439-44. PubMed ID: 11504920 [TBL] [Abstract][Full Text] [Related]
2. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330 [TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor metabolic dysfunction in Down's syndrome brains. Iulita MF; Do Carmo S; Ower AK; Fortress AM; Flores Aguilar L; Hanna M; Wisniewski T; Granholm AC; Buhusi M; Busciglio J; Cuello AC Brain; 2014 Mar; 137(Pt 3):860-72. PubMed ID: 24519975 [TBL] [Abstract][Full Text] [Related]
4. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Hunter CL; Bachman D; Granholm AC Ann Neurol; 2004 Nov; 56(5):675-88. PubMed ID: 15468085 [TBL] [Abstract][Full Text] [Related]
6. Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice. Kelley CM; Powers BE; Velazquez R; Ash JA; Ginsberg SD; Strupp BJ; Mufson EJ J Comp Neurol; 2014 Apr; 522(6):1390-410. PubMed ID: 24178831 [TBL] [Abstract][Full Text] [Related]
7. Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. Hunter CL; Isacson O; Nelson M; Bimonte-Nelson H; Seo H; Lin L; Ford K; Kindy MS; Granholm AC Neurosci Res; 2003 Apr; 45(4):437-45. PubMed ID: 12657457 [TBL] [Abstract][Full Text] [Related]
8. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome. Granholm AC; Sanders LA; Crnic LS Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084 [TBL] [Abstract][Full Text] [Related]
9. Retrograde axonal transport of BDNF and proNGF diminishes with age in basal forebrain cholinergic neurons. Shekari A; Fahnestock M Neurobiol Aging; 2019 Dec; 84():131-140. PubMed ID: 31574357 [TBL] [Abstract][Full Text] [Related]
10. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261 [TBL] [Abstract][Full Text] [Related]
11. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
12. Altered NGF response but not release in the aged septo-hippocampal cholinergic system. Williams B; Nelson M; Granholm AC; Coultrap S; Browning M; Curtis M Exp Neurol; 2005 Nov; 196(1):30-40. PubMed ID: 16137678 [TBL] [Abstract][Full Text] [Related]
14. A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model. Capsoni S; Brandi R; Arisi I; D'Onofrio M; Cattaneo A CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):635-47. PubMed ID: 21631402 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons. Bishop KM; Hofer EK; Mehta A; Ramirez A; Sun L; Tuszynski M; Bartus RT Exp Neurol; 2008 Jun; 211(2):574-84. PubMed ID: 18439998 [TBL] [Abstract][Full Text] [Related]
16. Delayed NGF infusion fails to reverse axotomy-induced degeneration of basal forebrain cholinergic neurons in adult p75(LNTR)-deficient mice. van der Zee CE; Hagg T Neuroscience; 2002; 110(4):641-51. PubMed ID: 11934472 [TBL] [Abstract][Full Text] [Related]
17. Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits. Chen KS; Nishimura MC; Armanini MP; Crowley C; Spencer SD; Phillips HS J Neurosci; 1997 Oct; 17(19):7288-96. PubMed ID: 9295375 [TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration. Holtzman DM; Li Y; Chen K; Gage FH; Epstein CJ; Mobley WC Neurology; 1993 Dec; 43(12):2668-73. PubMed ID: 8255474 [TBL] [Abstract][Full Text] [Related]
19. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Mufson EJ; Cochran E; Benzing W; Kordower JH Dementia; 1993; 4(5):237-50. PubMed ID: 7505157 [TBL] [Abstract][Full Text] [Related]
20. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Koliatsos VE; Clatterbuck RE; Nauta HJ; Knüsel B; Burton LE; Hefti FF; Mobley WC; Price DL Ann Neurol; 1991 Dec; 30(6):831-40. PubMed ID: 1789695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]